LEXICON PHARMACEUTICALS, INC. (LXRX) Operating margin 2017–2025
LEXICON PHARMACEUTICALS, INC. (LXRX) operating margin by fiscal year — reported operating income divided by reported revenue.
-98.2%FY2025 · since FY2017: -822.1% → -98.2%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -98.2% | +3186.5 pp |
| FY2024 | -3284.7% | +12188.2 pp |
| FY2023 | -15473.0% | — |
| FY2020 | -204.2% | -641.7 pp |
| FY2019 | 437.5% | +826.0 pp |
| FY2018 | -388.5% | +433.5 pp |
| FY2017 | -822.1% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice